Anna Brichkina

813 total citations
26 papers, 546 citations indexed

About

Anna Brichkina is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Anna Brichkina has authored 26 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Anna Brichkina's work include Epigenetics and DNA Methylation (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Neuroblastoma Research and Treatments (3 papers). Anna Brichkina is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Neuroblastoma Research and Treatments (3 papers). Anna Brichkina collaborates with scholars based in Germany, Russia and Singapore. Anna Brichkina's co-authors include Dmitry V. Bulavin, Dmitry A. Gorin, Maria N. Antipina, Weiping Han, Elena Kostromina, Xavier Le Guezennec, Anton M. Pavlov, Gleb B. Sukhorukov, Maxim V. Kiryukhin and Elena N. Vasina and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and Cell Metabolism.

In The Last Decade

Anna Brichkina

26 papers receiving 542 citations

Peers

Anna Brichkina
Comparison fields: 5 of 78
  • Molecular Biology 243
  • Biomaterials 94
  • Epidemiology 91
  • Oncology 83
  • Biomedical Engineering 82
Hyang‐Hwa Ryu South Korea
Elisa Pedone United Kingdom
Dejun Yang China
Ju-Ock Nam South Korea
Prajna Mishra India
Dongjun Luo China
Łukasz Mielańczyk Poland
Tessa M. Simone United States
Douglas A. Chapnick United States
Hyang‐Hwa Ryu South Korea View profile →
Citations per field, relative to Anna Brichkina
Anna Brichkina · 1×
Citations per year, relative to Anna Brichkina
Anna Brichkina · 1×

Countries citing papers authored by Anna Brichkina

Since Specialization
Citations

This map shows the geographic impact of Anna Brichkina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Brichkina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Brichkina more than expected).

Fields of papers citing papers by Anna Brichkina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Brichkina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Brichkina. The network helps show where Anna Brichkina may publish in the future.

Co-authorship network of co-authors of Anna Brichkina

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Brichkina. A scholar is included among the top collaborators of Anna Brichkina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Brichkina. Anna Brichkina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Mitochondrial, metabolic and bioenergetic adaptations drive plasticity of colorectal cancer cells and shape their chemosensitivity Cell Death and Disease Marina Gomzikova, Anna Brichkina et al. 2
2 Comprehensive analysis of cellular metrics: From proliferation to mitochondrial membrane potential and cell death in a single sample Cell Death Discovery Marina Gomzikova, Anna Brichkina et al. 2
3 Immunometabolism of tumor-associated macrophages: A therapeutic perspective European Journal of Cancer Yana Mukhamedshina, Albert A. Rizvanov et al. 11
4 A safe haven for cancer cells: tumor plus stroma control by DYRK1B Oncogene Anna Brichkina, Matthias Lauth et al. 2
5 In vitro functional assays to assess the reciprocal interplay between tumor cells and macrophages The FASEB Journal Marina Gomzikova, Yana Mukhamedshina et al. 1
6 DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer Gut Anna Brichkina, Rajeev Singh et al. 8
7 Mitochondrial Protein Density, Biomass, and Bioenergetics as Predictors for the Efficacy of Glioma Treatments International Journal of Molecular Sciences Marina Gomzikova, Anna Brichkina et al. 1
8 Pericentromeric satellite lncRNAs are induced in cancer-associated fibroblasts and regulate their functions in lung tumorigenesis Cell Death and Disease N. I. Enukashvily, Andrey D. Prjibelski et al. 12
9 A Quick Guide to CAF Subtypes in Pancreatic Cancer Cancers Anna Brichkina, Matthias Lauth et al. 23
10 Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment NAR Cancer Anna Brichkina, Florian Finkernagel et al. 2
11 A novel role for mitochondrial fission in macrophages: trained innate immunity induced by beta-glucan Cellular and Molecular Immunology Anna Brichkina, Hans‐Uwe Simon 7
12 DYRK3 contributes to differentiation and hypoxic control in neuroblastoma Biochemical and Biophysical Research Communications Anna Brichkina, Petra Ina Pfefferle et al. 7
13 The mammalian Hedgehog pathway is modulated by ANP32 proteins Biochemical and Biophysical Research Communications Anna Brichkina, Till Adhikary et al. 5
14 Activation of Cilia-Independent Hedgehog/GLI1 Signaling as a Novel Concept for Neuroblastoma Therapy Cancers Anna Brichkina, Florian Finkernagel et al. 9
15 p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis Genes & Development Anna Brichkina, Thomas Bertero et al. 41
16 Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions Cell Death and Differentiation Anna Brichkina, Rajamanickam Baskar et al. 16
17 Multilayer Capsules of Bovine Serum Albumin and Tannic Acid for Controlled Release by Enzymatic Degradation ACS Applied Materials & Interfaces Maria V. Lomova, Anna Brichkina et al. 137
18 Novel mechanism of JNK pathway activation by adenoviral E1A Oncotarget Anna Brichkina, Helen Morrison et al. 5
19 Wip1-Dependent Regulation of Autophagy, Obesity, and Atherosclerosis Cell Metabolism Xavier Le Guezennec, Anna Brichkina et al. 113
20 WIP-ing out atherosclerosis with autophagy Autophagy Anna Brichkina, Dmitry V. Bulavin 23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026